Design of a Phase 2a, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics of Multiple-Ascending Doses of PGN-EDO51 in Participants with Duchenne Muscular Dystrophy (DMD)
PGN-EDO51
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Design of a Phase 2a, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics of Multiple-Ascending Doses of PGN-EDO51 in Participants with Duchenne Muscular Dystrophy (DMD) ### Output: PGN-EDO51